Rothschild & Co Redburn Cuts Clorox (NYSE:CLX) Price Target to $115.00

Clorox (NYSE:CLX) had its target price trimmed by Rothschild & Co Redburn from $120.00 to $115.00 in a research report sent to investors on Wednesday,MarketScreener reports. The brokerage currently has a neutral rating on the stock.

Several other equities analysts have also weighed in on the stock. Zacks Research lowered shares of Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, October 28th. The Goldman Sachs Group cut their price target on Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research note on Wednesday, October 1st. Citigroup cut their price objective on Clorox from $130.00 to $120.00 and set a “neutral” rating for the company in a research report on Tuesday. JPMorgan Chase & Co. decreased their target price on Clorox from $127.00 to $120.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $152.00 price target on shares of Clorox in a research note on Tuesday. One equities research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and five have given a Sell rating to the company’s stock. According to MarketBeat, Clorox has a consensus rating of “Reduce” and a consensus price target of $125.69.

Clorox Stock Performance

Clorox stock traded up $1.09 during trading hours on Wednesday, hitting $107.37. 1,843,132 shares of the stock traded hands, compared to its average volume of 1,706,862. The firm’s 50 day moving average price is $119.49 and its 200-day moving average price is $124.94. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The stock has a market capitalization of $13.07 billion, a price-to-earnings ratio of 16.47, a P/E/G ratio of 0.92 and a beta of 0.52. Clorox has a 1 year low of $106.14 and a 1 year high of $171.37.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.78 by $0.07. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the prior year, the company earned $1.86 EPS. Clorox’s quarterly revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities analysts expect that Clorox will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd were issued a dividend of $1.24 per share. The ex-dividend date of this dividend was Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.6%. Clorox’s dividend payout ratio is presently 77.86%.

Insider Buying and Selling at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.63% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in CLX. Horizon Investments LLC lifted its stake in Clorox by 4.4% during the 1st quarter. Horizon Investments LLC now owns 1,768 shares of the company’s stock worth $258,000 after acquiring an additional 75 shares in the last quarter. Sfmg LLC increased its stake in Clorox by 2.8% during the first quarter. Sfmg LLC now owns 2,780 shares of the company’s stock worth $409,000 after purchasing an additional 76 shares during the period. Hancock Whitney Corp boosted its stake in shares of Clorox by 4.3% in the first quarter. Hancock Whitney Corp now owns 2,064 shares of the company’s stock valued at $304,000 after purchasing an additional 86 shares during the period. Brown Lisle Cummings Inc. grew its holdings in shares of Clorox by 4.3% in the second quarter. Brown Lisle Cummings Inc. now owns 2,136 shares of the company’s stock valued at $256,000 after purchasing an additional 89 shares in the last quarter. Finally, American National Bank & Trust increased its stake in Clorox by 69.5% during the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after buying an additional 89 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.